Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9728adba1e7465a13f8ccf148bc93d50 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6801 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-65 |
filingDate |
2020-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2d57a91f7407d7ab5d9d62e3f0c229 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a509f6f1edee9b31a46ff4c0a2b64ef2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ecc9c2ee05f5801e6b8b86f990ab51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5599df5ec6e7ed46ded78e5998df2dea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a618fcdca75f2be64421d1c7271da5e |
publicationDate |
2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2020234394-A1 |
titleOfInvention |
Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof |
abstract |
The present application relates to a technology enabling a specific number of chemical functional groups or cargo moieties to be labeled at specific sites of an antibody. An antibody product having high uniformity can be provided by the present application. In addition, an antibody product in which functions of the antibody do not decline can be provided by the present application. That is, an antibody product of which avidity and half-life do not decline can be provided. The present application is very meaningful by being the first technology that enables site-specific labeling of antibodies without a complicated process. |
priorityDate |
2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |